Earle A. Chiles Research Institute

Located within the Robert W. Franz Cancer Center in Portland, Oregon, the Earle A. Chiles Research Institute, a division of Providence Cancer Institute, is a world-class research facility led by Walter J. Urba, MD, PhD, and a team of globally renowned physicians and scientists.

Since 1993, our main area of investigation is cancer immunotherapy, a specialized field of study focused on harnessing the power of the immune system to cure cancer. Our scientists and clinicians work together to improve the standard of care through the integration of clinical trials into medical practice.

With a research team of more than 150, the Earle A. Chiles Research Institute garners more than $5 million annually in federal, private and sponsored research funding. Learn more.

Advances in Cancer Immunotherapy

Free virtual event for health care professionals, students, patients and patient advocates. Stay current with FDA-approved immunotherapy treatments.

Providence Cancer Institute announces newly Endowed Chair

Dr. Marka Crittenden receives honor as the first recipient of the Michael Kelley Endowed Chair for Cancer Research.

The Power of Precision Immunotherapy

Learn how we are combining immunotherapy and genomics for precision cancer care.

Immunotherapy is a Game-Changer in Cancer Research

Learn how immunotherapy has ushered in a revolution in cancer research and care.

Celebrating 20 years of Immunotherapy Research

Learn how Providence Cancer Institute became a leading institution for cancer immunotherapy research and treatment.

Dr. Urba honored as 'cancer warrior'

The Oregon Historical Society recognized Walter J. Urba, M.D., Ph.D., as a 2014 Oregon History Maker, referencing him as a "cancer warrior."